Clinical Trials (DCTs) Market, Global Outlook
and Forecast 2022-2028 Market
Decentralized Clinical Trials (DCTs) Market, Global Outlook and Forecast 2022-2028 Market Scope: Industry Analysis, Market Size, Growth, Trends Till 2031
Request Sample Report
Decentralized Clinical Trials (DCTs) Market, Global Outlook and Forecast 2022-2028 Market Size and Growth
The global Decentralized Clinical Trials (DCTs) market is expected to experience significant growth between 2022-2028 due to increasing adoption of digital technologies in clinical research. Market size is projected to reach $3.5 billion by 2028, driven by the benefits of remote patient monitoring and reduced costs associated with traditional trials.
Companies Covered
(Covid 19 Impact Covered)
◍ ICON Plc
◍ LEO Innovation Lab
◍ Science 37
◍ PRA Health Sciences
◍ Clinical Ink
◍ Parexel
◍ Medable
◍ Oracle
◍ CRF Health
◍ Medidata
◍ Covance
◍ IQVIA
◍ PPD
◍ PWNHealth, LLC
◍ Medrio
The competitive landscape of Decentralized Clinical Trials (DCTs) Market is led by companies like ICON Plc, LEO Innovation Lab, Science 37, PRA Health Sciences, Clinical Ink, Parexel, Medable, Oracle, CRF Health, Medidata, Covance, IQVIA, PPD, PWNHealth, LLC, and Medrio. These companies leverage DCTs technology to streamline clinical trial processes and improve patient access, leading to market growth.
- ICON Plc reported sales revenue of $2.75 billion.
- PRA Health Sciences reported sales revenue of $3.22 billion.
- IQVIA reported sales revenue of $9.22 billion. Request Sample Report
Market Segmentation
By Application
Oncology
Cardiovascular Disease
Others
Request Sample Report
By Product
Interventional Trials
Observational Trials
Expanded Access Trials
Market Growth
Request Sample Report
$ X Billion USD
